X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (17) 17
humans (14) 14
animals (8) 8
oncology (7) 7
glioblastoma (6) 6
glioblastoma - genetics (6) 6
angiogenesis (5) 5
brain neoplasms - genetics (5) 5
brain neoplasms - metabolism (5) 5
brain neoplasms - pathology (5) 5
gene expression (5) 5
glioblastoma - pathology (5) 5
invasion (5) 5
rats (5) 5
stem cells (5) 5
cancer (4) 4
cell line, tumor (4) 4
clinical neurology (4) 4
egfr (4) 4
expression (4) 4
glioblastoma - metabolism (4) 4
in-vivo (4) 4
mitochondria (4) 4
mutation (4) 4
tumors (4) 4
biochemistry & molecular biology (3) 3
brain cancer (3) 3
development and progression (3) 3
gene-expression (3) 3
health aspects (3) 3
male (3) 3
pathology (3) 3
research (3) 3
tumor cells, cultured (3) 3
xenograft model antitumor assays (3) 3
aged (2) 2
amp (2) 2
analysis (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
brain (2) 2
brain tumors (2) 2
brain-tumors (2) 2
breast cancer (2) 2
breast-cancer (2) 2
cell culture (2) 2
cell metabolism (2) 2
cell transformation, neoplastic - pathology (2) 2
cetuximab (2) 2
cross-contamination (2) 2
cultures (2) 2
disease (2) 2
disease progression (2) 2
dna fingerprinting (2) 2
drug resistance (2) 2
epidermal growth factor (2) 2
female (2) 2
genetic aspects (2) 2
genomes (2) 2
genomics (2) 2
glioblastoma - drug therapy (2) 2
glioblastoma multiforme (2) 2
glioma-cells (2) 2
gliomas (2) 2
growth-factor receptor (2) 2
kinases (2) 2
laboratories (2) 2
lines (2) 2
medical prognosis (2) 2
medical research (2) 2
mesenchymal stem cells (2) 2
mesenchymal stromal cells - pathology (2) 2
metabolism (2) 2
metastasis (2) 2
middle aged (2) 2
mitochondrial dna (2) 2
molecular targeted therapy (2) 2
multidisciplinary sciences (2) 2
neovascularization, pathologic (2) 2
neovascularization, pathologic - metabolism (2) 2
nestin (2) 2
neurosciences (2) 2
prognosis (2) 2
qpcr (2) 2
quantification (2) 2
rats, nude (2) 2
receptor, epidermal growth factor - genetics (2) 2
receptor, epidermal growth factor - metabolism (2) 2
research article (2) 2
resistance (2) 2
rna, messenger - metabolism (2) 2
spontaneous malignant-transformation (2) 2
spontaneous transformation (2) 2
str analysis (2) 2
surgery (2) 2
transcriptional activation (2) 2
transformed mesenchymal cell (2) 2
tumor-growth (2) 2
2-acetic acid (1) 1
ac133 antigen (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochemical and Biophysical Research Communications, ISSN 0006-291X, 12/2018, Volume 506, Issue 4, pp. 923 - 926
We show that the quantitative PCR reaction volume can be reduced significantly compared to the standard procedures, without compromising data quality. By... 
qPCR | Nano-scale qPCR | TaqMan technology | BIOPHYSICS | QUANTIFICATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | Tag Man technology | PCR | Cell Line, Tumor | Reference Standards | Nanotechnology - methods | Humans | Real-Time Polymerase Chain Reaction - methods | Polymerase chain reaction | Information management | Gene expression | Analysis | Robots | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 04/2012, Volume 72, Issue 8 Supplement, pp. 5279 - 5279
Journal Article
Cancer Research, ISSN 0008-5472, 02/2013, Volume 73, Issue 3 Supplement, pp. B84 - B84
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 5/2013, Volume 125, Issue 5, pp. 683 - 698
Journal Article
Neuro-Oncology, ISSN 1522-8517, 2016, Volume 18, Issue 12, pp. 1 - 12
Journal Article
Neuro-oncology, ISSN 1522-8517, 2017, Volume 19, Issue 3, pp. 383 - 393
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2013, Volume 8, Issue 12, pp. e81183 - e81183
Journal Article
Experimental Cell Research, ISSN 0014-4827, 03/2012, Volume 318, Issue 5, pp. 441 - 443
Journal Article
JCI INSIGHT, ISSN 2379-3708, 12/2016, Volume 1, Issue 21, pp. e89376 - e89376
Myalgic encephalopathy/chronic fatigue syndrome (ME/CFS) is a debilitating disease of unknown etiology, with hallmark symptoms including postexertional malaise... 
MEDICINE, RESEARCH & EXPERIMENTAL | ACID | PRIMARY BILIARY-CIRRHOSIS | DISEASE | INCREASED VENTRICULAR LACTATE | SERUM | REGIONAL PAIN SYNDROME | DYSFUNCTION | EXPRESSION | MASS-SPECTROMETRY | EXERCISE
Journal Article
Journal of Lipid Research, ISSN 0022-2275, 2017, Volume 58, Issue 7, pp. 1362 - 1373
Hepatic mitochondrial function, APOC-III, and LPL are potential targets for triglyceride (TG)-lowering drugs. After 3 weeks of dietary treatment with the... 
Lipoproteins | Mitochondria | Uncoupling protein | Apolipoprotein C-III | Fatty acid metabolism | Fatty acid | 2-(tridec-12-yn-1-ylthio)acetic acid | Lipids | Nonalcoholic fatty liver disease | Metabolic syndrome | Triglyceride | Lipids/oxidation | triglyceride | TRIGLYCERIDE TRANSFER PROTEIN | MAMMALIAN-TISSUES | CARNITINE | lipids | TETRADECYLTHIOACETIC ACID TTA | lipids/oxidation | mitochondria | fatty acid metabolism | LIPID LEVELS | BIOCHEMISTRY & MOLECULAR BIOLOGY | fatty acid | apolipoprotein C-III | HYPERTRIGLYCERIDEMIA | uncoupling protein | metabolic syndrome | nonalcoholic fatty liver disease | MALONYL-COA | DISEASE | GENE-EXPRESSION | lipoproteins | Oxidation-Reduction | Rats, Wistar | Mitochondria, Liver - metabolism | Liver - metabolism | Apolipoprotein C-III - metabolism | Rats | Acetic Acid - pharmacology | Male | Acetic Acid - chemistry | Carnitine - metabolism | Mitochondrial Uncoupling Proteins - metabolism | Triglycerides - metabolism | Mitochondria, Liver - drug effects | Animals | Liver - drug effects | Triglycerides - blood | Acetylcarnitine - metabolism | Fatty Acids - metabolism | Energy Metabolism - drug effects | Mitochondrial uncoupling protein 2 | AMP | Cardiac muscle | Liver | Ketone bodies | Mitochondrial DNA | Lipoprotein lipase | Gene expression | Lipoproteins (very low density) | Cytochrome c | Rodents | Oxidation | Acetic acid | Index Medicus | oxidation
Journal Article
International Journal of Cancer, ISSN 0020-7136, 04/2019, Volume 144, Issue 7, pp. 1735 - 1745
Glioblastoma multiforme (GBM) has a poor prognosis with an overall survival of 14–15 months after surgery, radiation and chemotherapy using temozolomide (TMZ).... 
temozolomide | glioblastoma | autophagy | drug resistance | thioridazine | SURVIVAL | ANGIOGENESIS | NEWLY-DIAGNOSED GLIOBLASTOMA | CONNECTIVITY MAP | CELLULAR-DISTRIBUTION | RADIATION | ADJUVANT TEMOZOLOMIDE | TRIAL | ONCOLOGY | RESISTANCE | TUMOR-GROWTH | Lysosomes - drug effects | Cell Survival - drug effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Brain Neoplasms - genetics | Thioridazine - administration & dosage | Synthetic Lethal Mutations | Brain Neoplasms - drug therapy | Autophagy - drug effects | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Drug Synergism | Temozolomide - therapeutic use | Xenograft Model Antitumor Assays | Autophagosomes - drug effects | Animals | Glioblastoma - genetics | Temozolomide - administration & dosage | Thioridazine - pharmacology | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Glioblastoma - drug therapy | Drug Resistance, Neoplasm - drug effects | RNA | Genes | Brain tumors | Genomics | Drug resistance | Antineoplastic agents | Gene expression | Glioblastoma multiforme | Antimitotic agents | Chemotherapy | Analysis | Health aspects | Phenothiazine | Cancer | Brain | Neuroleptics | Toxicity | Brain cancer | Glioblastoma | Radiation | Phagosomes | Lysosomes | Genomes | Lethality | Drug development | Autophagy | Psychotropic drugs | Surgery | Biocompatibility | RNA-mediated interference | Feasibility studies | Pharmacology | Sensitivity | Thioridazine | Ribonucleic acids | Neural networks | Medical prognosis | Glioblastoma cells | Temozolomide | Phagocytosis | Tumors | Index Medicus
Journal Article